Biozona Weekly: Desert Angels; Ovarian cancer biomarkers; Tucson entrepreneurship

April 29, 2015

By Amy Pitney

Institute at Phoenix hospital region’s busiest for lung transplants
4/27/15 | Arizona Republic | Samantha Incorvaia (Cronkite News)

Dignity Health St. Joseph’s John and Doris Norton Thoracic Institute had the fifth-busiest lung-transplant program in the nation last year with 73 lung transplants performed by surgeons.

Tucson’s new focus on entrepreneurship, startups, retention and expansion

4/25/15 | Arizona Daily Star | Joe Ferguson

A grow-our-own economic-development strategy is taking root in Tucson, being fueled by a larger wave of university-driven tech startups and patents and the growth of business incubators and mentoring centers.

Rapid growth in bioscience industry in peril
4/22/15 | Arizona Capitol Times | Megan Janetsky

Budget cuts to the state’s universities and other factors are raising concerns that the slowing of the Arizona bioscience industry’s growth may be inevitable, hampering the state’s overall economy.

Once cash cows, university hospitals now source of worry for schools

4/22/15 | Wall Street Journal | Melissa Korn

Moody’s raised its outlook on the University of Arizona to stable from negative last month after the school’s struggling hospitals, clinics and insurance company were acquired by nonprofit Banner Health, an example of leading schools rethinking their health care operations.

PHX incubator, PADT offer 3-D printers for makers/entrepreneurs needing rapid prototypes
4/21/15 | Phoenix Business Journal | Hayley Ringle

The Center for Entrepreneurial Innovation, a Phoenix incubator on the campus of GateWay Community College, is now offering startups rapid prototyping and medical device help through two new partnerships.

Desert Angels ranks third in nation in investment activity in 2014
4/20/15 | Phoenix Business Journal | Hayley Ringle

The Desert Angels of Tucson has been ranked as the third most active angel group in the nation after investing more than $6.8 million in 32 companies in 2014, according to “The Halo Report.”

Paradigm teams up with TD2 for tumor profiling service
4/20/15 | GenomeWeb | Staff Report

Paradigm, a spinout of International Genomics Consortium of Phoenix, announced a partnership to provide its PCDx next-generation sequencing-based cancer diagnostic test to Translational Drug Development’s (TD2) affiliated oncology provider networks.

Five Arizona companies raise $30M in venture deals
4/17/15 | Phoenix Business Journal | Eric Jay Toll

Five Arizona businesses, including two bioscience companies, raised $31 million in new venture capital during the first quarter, according to a new report.

ASU researchers find potential clues to detecting ovarian cancer
4/15/15 | Cronkite News | Meryl Fishler

Researchers from the Biodesign Institute at Arizona State University said they have identified three promising biological signals that could help detect ovarian cancer before patients display any symptoms.